# Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

> **NCT02023489** · NA · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 90 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
- Familiar Hypocalcuric Hypercalcemia
- Healthy Volunteers
- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** 1H/ 13C and 31P Magnetic Resonance Spectroscopy
- **OTHER:** Meal Tolerance Test
- **OTHER:** Hyperglycemic-hyperinsulinemic clamp

## Key facts

- **NCT ID:** NCT02023489
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2017-12
- **Final completion:** 2018-07
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2017-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02023489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02023489, "Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02023489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
